about
A comparison of different human papillomavirus tests in PreservCyt versus SurePath in a referral population-PREDICTORS 4Performance of the Xpert HPV assay in women attending for cervical screening.In Regard to Vaidya et al(Preprint)Validation of the OncoMasTR Risk Score in Estrogen Receptor-Positive/HER2-Negative Patients: A TransATAC studyMeasurement challenge: protocol for international case-control comparison of mammographic measures that predict breast cancer riskRole of HPV Genotype, Multiple Infections, and Viral Load on the Risk of High-Grade Cervical NeoplasiaKey steps for effective breast cancer preventionPrognostic Value of EndoPredict in Women with Hormone Receptor Positive, HER2-Negative Invasive Lobular Breast Cancer
P50
Q30276176-B6668ED8-D499-42F1-BA46-811983EC2D7AQ55259586-E718A5B3-0C82-4727-82F4-A84B793A9B40Q57618082-7078C8E3-CEA1-4DC7-872E-3B5CCE5C4F77Q58198339-6018E4E5-5FE9-49EC-8DBB-0053D4A67BF6Q90882508-1AC01DCB-B3D7-46F6-B440-729535DD72E6Q92356630-E2E09281-C98F-4031-AD72-B8B8942719E8Q93130713-7DBF4BDE-903A-4421-B83E-579B5CB9641DQ96302976-727343C4-EBB4-4B87-B41C-024E33E7FDD7Q96609091-C1345C7D-5477-4091-B75F-BCC2DCB8CF82
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Jack Cuzick
@ast
Jack Cuzick
@en
Jack Cuzick
@es
Jack Cuzick
@nl
type
label
Jack Cuzick
@ast
Jack Cuzick
@en
Jack Cuzick
@es
Jack Cuzick
@nl
prefLabel
Jack Cuzick
@ast
Jack Cuzick
@en
Jack Cuzick
@es
Jack Cuzick
@nl
P106
P31
P496
0000-0001-7420-7512